Latest Research | Long Covid
Latest long COVID research explores persistent symptoms, underlying mechanisms, and potential treatments. Studies reveal multi-system impacts, including cardiovascular, neurological, and respiratory issues. Researchers are investigating biomarkers for diagnosis and effective therapeutic interventions. Emerging data suggest the importance of vaccination in reducing long COVID risk. Ongoing trials aim to identify targeted therapies to alleviate prolonged symptoms and improve patient outcomes.
Canada’s Task Force Highlights Challenges and Recommendations for Post-COVID-19 Condition (PCC) Summary Consultative roundtables in 2022 emphasized the prevalence of Post-COVID-19 condition (PCC) in Canada, estimated to affect 10-20% of SARS-CoV-2 infected individuals. PCC lacks a unified definition, making diagnosis challenging, and the virus’s interaction with ACE2 is identified as a key aspect. The need
Economic costs of long Covid in the UK. Latest research study
A study reveals a surge in COVID-19-associated orphan-hood, with 5.2 million children affected globally by Oct 2021
POTS and IST Complexity: Management involves lifestyle changes and targeted pharmacological interventions, addressing fluid and sodium intake, physical exercises, and cautious exercise introduction in post-COVID cases.